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Abstract: Diabetes mellitus (DM) and obesity are believed to be risk factors for colorectal cancer in humans. In ex-
periment 1, male nondiabetic Long-Evans Tokushima Otsuka (LETO) rats and Otsuka Long-Evans Tokushima Fatty 
(OLETF) rats, a model animal of type 2 DM, were whole-body X-irradiated (4 Gy) at 6 and 8 weeks of age and eutha-
nized at 78 weeks of age (n=15, respectively). The incidences of small intestine adenocarcinoma in LETO and OLETF 
rats were 0% and 30%, respectively. In experiment 2, male LETO and OLETF rats (n=24, respectively) were given s.c. 
injections of 15 mg/kg azoxymethane (AOM) once weekly for 3 weeks and euthanized at 36 weeks of age. The inci-
dences of Zymbal gland tumors in LETO and OLETF rats were 0% and 67%, respectively (P<0.001), whereas those of 
small intestine adenocarcinoma were 0% and 43% (P<0.001) and those of cecum/colon adenocarcinoma were 46% and 
79% (P<0.05), respectively. Fatty change of hepatocytes was common in OLETF rats (63%) but not in LETO rats. Serum 
triglyceride and free fatty acid levels in OLETF rats were significantly higher than in LETO rats at sacrifice, whereas 
serum insulin levels in OLETF rats were very diverse. These data suggest that hyperlipidemia plays a significant role 
in high susceptibility to lower intestinal tract carcinogenesis in OLETF rats; this strain is susceptible to AOM-induced 
Zymbal gland carcinogenesis.  (DOI: 10.1293/tox.24.187; J Toxicol Pathol 2011; 24: 187–193)
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Introduction
Epidemiologic studies have suggested a positive link 
between diabetes mellitus (DM) and various neoplasms 
including colon cancer1,2. Obesity is a risk factor for DM 
and cancer of various organs including the colon3,4. Insulin 
resistance, chronic inflammation and/or altered adipokine 
secretion with resultant hyperlipidemia may be involved in 
DM and obesity-related cancer5. Exogenous insulin use may 
also be a risk factor for colorectal cancer6.
Otsuka Long-Evans Tokushima Fatty (OLETF) rats7, 
established from a closed colony of Long-Evans rats by 
selective breeding along with nondiabetic Long-Evans 
Tokushima Otsuka (LETO) rats, are a model animal of type 
2 DM and show late conversion to insulin-dependent dis-
ease. This strain has mild obesity, and a homozygous de-
letion in cholecystokinin-1 (CCK1) receptor gene respon-
sible  for  hyperphagia  has  been  identified8,9. OLETF rats 
are susceptible to N-nitrosobis(2-oxopropyl)amine-induced 
thyroid carcinogenesis10. In the present study, we examined 
X-irradiation and azoxymethane (AOM)-induced carcino-
genesis in LETO and OLETF rats.
Materials and Methods
Animals
LETO and OLETF rats were obtained from Otsuka 
Pharmaceutical Co., Ltd., Tokushima, Japan. Animals were 
housed three to a plastic cage with sterilized woodchips for 
bedding in an air-conditioned room at 23 ± 2 °C and 55 ± 
10% humidity with a 12-h light/dark cycle and given pellet 
diet (Oriental MF; Oriental Yeast Co., Ltd., Tokyo, Japan) 
and tap water ad libitum. Experiments were conducted ac-
cording to the Guidelines for the Care and Use of Laborato-
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ry Animals of the University of Tokushima, and the experi-
mental protocol was approved by the Animal Committee.
Carcinogenicity study
Experiment 1: After a 1-week acclimation period, six-
week-old male LETO and OLETF rats (n=15, respectively) 
were whole-body X-irradiated (4 Gy) at 6 and 8 weeks of 
age (Fig. 1). Three animals were put into an acrylic resin box 
and irradiated at a dose rate of 1.54 Gy/min using an X-ray 
irradiation system (Hitachi MBR-1520R-3; Hitachi Medi-
cal Corporation, Tokyo, Japan). Control animals (n=15, re-
spectively) were maintained for approximately 2 min in the 
chamber without irradiation (sham-irradiated). Body weight 
was monitored every other week, and all animals were eu-
thanized at 78 weeks of age under carbon dioxide narco-
sis. The stomach and intestine were opened, and the size 
and location of tumors were recorded; the tumors were then 
fixed in 10% buffered formalin and embedded in paraffin. 
For histological examination, tissue sections were stained 
with hematoxylin and eosin. Other major organs were also 
examined histologically. At 12 and 42 weeks of age, control 
rats were submitted to an oral glucose tolerance test (OGTT) 
after 16-h fasting in experiment 1 (n=9). Glucose (Wako 
Pure Chemical Industries, Ltd., Osaka, Japan) was given by 
gavage, 2 g/kg body weight, at about 10 a.m. Blood was col-
lected from the tail. Thirty-minute postglucose load blood 
glucose was measured by the glucose oxidase method. Se-
rum insulin was measured using an ELISA kit (Morinaga 
Institute of Biological Science, Yokohama, Japan).
Experiment 2: AOM was purchased from Wako Pure 
Chemical Industries, Ltd. Six-week-old male LETO and 
OLETF rats (n=24, respectively) were given s.c. injections 
of AOM at a dose of 15 mg/kg body weight once weekly 
for 3 weeks (Fig. 1). AOM was dissolved in 0.9% NaCl just 
before use. Animals were euthanized at 36 weeks of age. 
Blood samples were collected from the inferior vena cava 
at sacrifice (n=9, respectively), and the serum to examine 
insulin, triglyceride, free fatty acid and total cholesterol was 
frozen at –30 °C until use. Serum lipids were measured by 
SRL Inc., Tokyo, Japan. Histological examination of organs 
including neoplasms was performed.
Quantitative real-time RT-PCR
Livers from untreated 24-week-old male LETO and 
OLETF rats (n=5, respectively) were stabilized with RNAl-
ater (Applied Biosystems, Carlsbad, CA, USA) at 4 °C over-
night and then total RNAs were isolated using an RNeasy® 
Mini Kit (QIAGEN, Valencia, CA, USA). By using 1-µg 
aliquots, cDNAs were synthesized with SuperScript II re-
verse transcriptase and random hexamers (Invitrogen, 
Carlsbad, CA, USA). Reactions were conducted at 42 °C for 
60 min, and then the temperature was increased to 72 °C 
for 15 min. The total cDNAs were then subjected to quanti-
tative real-time RT-PCR (qRT-PCR) by the comparative Ct 
method. Each sample was mixed with SYBR Premix Ex Taq 
II (Takara Bio, Shiga, Japan) and specific primers for in-
sulin-like growth factor (IGF)-1, plasminogen activator in-
hibitor (Pai)-1 and β-actin, according to the manufacturer’s 
guidelines. β-Actin was used as an internal standard. These 
samples were then amplified using a 7500 Real-time PCR 
System (Applied Biosystems), and the data were analyzed 
with 7500 System SDS software (Applied Biosystems). 
Thermocycling program was as follows: 95 °C for 30 s for 
initial denaturation and 40 cycles of 95 °C for 5 s and 60 °C 
for  34 s  for  amplification.  The  sequences  of  the  primers 
were as follows: IGF-1-F, 5′-TTCAGTTCGTGTGTGGAC-
CAAG-3′; IGF-1-R, 5′-GATCACAGCTCCGGAAGCAA-3′; 
Pai-1-F,  5′-GCCCAGCATTCAGCCTTTG-3′;  Pai-1-R, 
5′-AAGACTTTGCTGAGTGAAGGCGTAG-3′;  β-actin-F, 
5′-GGAGATTACTGCCCTGGCTCCTA-3′; and β-actin-R, 
5′-GACTCATCGTACTCCTGCTTGCTG-3′.
Measurement of food intake
Male LETO and OLETF rats were given pellet diet, and 
food intake and body weight were monitored every other 
week until 20 weeks of age (n=15, respectively).
Statistical analyses
The incidence of tumors was analyzed by Fisher’s ex-
act probability test; other data were analyzed by two-tailed 
Student’s t-test.
Results
Experiment 1
The Average body weight of X-irradiated OLETF 
rats was found to be increased at sacrifice because of huge 
soft tissue sarcomas in some rats (Fig. 2). X-irradiation 
increased the incidence of various tumors in both strains 
(Table 1). Small intestinal adenocarcinomas developed in 3 
OLETF rats (30%), but not in LETO rats. The colonic tu-
mor in the X-irradiated OLETF rat was a leiomyosarcoma. 
X-irradiation caused a low incidence of islet cell tumors 
in both strains. Hyperglycemia at 12 and 42 weeks of age 
and hyperinsulinemia at 42 weeks of age were observed in 
control OLETF rats (Fig. 3). X-irradiation increased blood 
glucose levels and reduced insulin levels in OLETF rats 
compared with the control at 42 weeks of age, although not 
significantly, whereas these parameters were not affected by 
Fig. 1.  Experimental design for X-irradiation and AOM-induced car-
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X-irradiation in LETO rats.
Experiment 2
The average body weight of OLETF rats was higher 
than that of LETO rats throughout the experimental period 
(Fig. 4). The incidence of Zymbal gland, small intestine and 
colon tumors in OLETF rats was significantly higher than in 
LETO rats (Table 2). Malignant lymphoma developed in one 
LETO rat, but no other tumors developed in either strain. 
Fig. 2.  Growth curves of male LETO and OLETF rats in X-irradia-
tion-induced carcinogenesis.
Table 1.  Incidence of Tumors in 4-Gy X-irradiated Male LETO and OLETF Rats
Strain
Tumors
No. of Lung Kidney Small Colon Pancreatic Soft
rats intestine islet tissue
Sham-irradiated
  LETO 15 0 0 0 0 0 1 (7%)
  OLETF 15 0 0 0 0 0 1 (7%)
4-Gy X-irradiated
  LETO 13
a 0 5 (38%) 0 0 1 (8%) 7 (54%)
  OLETF 10
b 2 (20%) 3 (30%) 3 (30%) 1 (10%) 3 (30%) 4 (40%)
a Two rats died of unknown cause at 24 and 45 weeks of age. b Four rats died of severe diabetes at 12, 12, 13 and 20 weeks of 
age, and one rat died accidentally at 42 weeks of age.
Fig. 3.  Average blood glucose and serum insulin levels in LETO and 
OLETF rats at 12 and 42 weeks of age in an oral 2 g/kg OGTT 
(experiment 1). A, sham-irradiated rats; B, X-irradiated (4 
Gy) rats. *, ** and ***; P<0.05, P<0.01 and P<0.001, respec-
tively, versus LETO rat (two-tailed Student’s t-test). □, LETO 
rat; ■, OLETF rat; Bars, SD.
Fig. 4. Growth curves of male LETO and OLETF rats in 
AOM-induced carcinogenesis.
Fig. 5.  Average no. of small intestine and colon tumors in 
LETO and OLETF rats (experiment 2). The average 
no. of colon tumors in OLETF rats was 2.1 times high-
er than in LETO rats. * and **; P<0.01 and P<0.001, 
respectively, versus LETO rats (two-tailed Student’s 
t-test). □, LETO rat; ■, OLETF rat; Bars, SD.Carcinogenesis in LETO and OLETF Rats 190
Fig. 6.  AOM-induced Zymbal gland tumors in OLETF rats. A, bilateral Zymbal gland tumors in an OLETF rat; B, sebaceous carci-
noma of the Zymbal gland. Bar, 100 µm.
Fig. 7.  Histological appearance of AOM-treated LETO and OLETF rats (experiment 2). A, liver of a LETO rat; B, liver of an OLETF rat; C, 
pancreatic islets of a LETO rat; D, pancreatic islets of an OLETF rat. Bars, 100 µm.Hafez, Takahashi, Ogawa et al. 191
The average numbers of small intestine and colon tumors in 
OLETF rats were higher than in LETO rats (Fig. 5). These 
tumors were mainly tubular adenocarcinoma histologically, 
and signet-ring cell carcinoma developed in one LETO rat. 
In one OLETF rat, colonic cancer metastasized to a retro-
peritoneal lymph node. Six of the 16 Zymbal gland tumors 
in OLETF rats, sebaceous carcinoma histologically, were bi-
lateral (Fig. 6). The incidence of fatty change of hepatocytes 
was 15/24 (63%) in OLETF rats and 0% in LETO rats (Fig. 
7). Pancreatic islets of OLETF rats showed hemosiderosis, 
loss of islet cells and fibrosis. The average serum insulin 
level in OLETF rats was lower than in LETO rats (Fig. 8). 
The insulin levels in 2 of 9 OLETF rats were higher than the 
maximum value in LETO rats, but those in 5 OLETF rats 
were lower than the minimum value in LETO rats. Serum 
triglyceride and free fatty acid levels in OLETF rats were 
significantly higher than in LETO rats at sacrifice.
Analysis of the liver
The relative expression levels of liver IGF-1 and Pai-1 
mRNA in OLETF rats were 1.08 ± 0.23-fold and 1.63 ± 0.45-
Fig. 8.  Serum insulin, triglyceride, free fatty acid and total cholesterol in LETO and OLETF rats at 
36 weeks of age (experiment 2). * and **; P < 0.05 and P < 0.01, respectively, versus LETO 
rats (two-tailed Student’s t-test). A, insulin; B, triglyceride; C, free fatty acid; D, total cho-
lesterol. □, LETO rat; ■, OLETF rat; Bars, SD.
Fig. 9.  Expression of IGF-1 and Pai-1 mRNA in the liver of LETO 
and OLETF rats (n=5). Relative expression levels of IGF-1 
and Pai-1 mRNA were detected by qRT-PCR. Bars, SD. Fig. 10.  Food intake/body weight ratio in LETO and OLETF rats. □, 
LETO rat; ■, OLETF rat.
Table 2.  Incidence of AOM-induced Tumors in Male LETO and OLETF Rats
Strain
No. of
 rats
Tumors
Zymbal gland Small intestine Colon
LETO 24 0 0 11 (46%)
OLETF 24
a 16 (67%)*** 9 (38%)** 19 (79%)*
a One rat died of colonic and Zymbal gland tumors at 20 weeks of age. Five rats were euthanized at 29, 31, 32, 33 and 
34 weeks of age due to colonic and/or Zymbal gland tumors. *, ** and ***; P<0.05, P<0.01 and P<0.001, respec-
tively, versus LETO rats (Fisher's exact probability test).Carcinogenesis in LETO and OLETF Rats 192
fold, respectively, those in LETO rats. No significant differ-
ences were observed between the strains (Fig. 9).
Food intake
The average food intakes of the untreated LETO and 
OLETF rats were 18.5 g and 26.0 g, respectively. The food 
intake/body weight ratio in OLETF rats was 1.08–1.19 times 
higher than in LETO rats (Fig. 10).
Discussion
X-irradiation induced a low incidence of intestinal can-
cer in OLETF rats, but not in LETO rats, and OLETF rats 
were clearly susceptible to AOM-induced Zymbal gland and 
lower intestinal tract carcinogenesis. Zucker obese rats, a 
model animal with leptin receptor gene mutation with hy-
perleptinemia, exhibit marked obesity and type 2 DM11,12. 
Zucker obese rats are also more susceptible to AOM-induced 
colon cancer than control Zucker lean rats13,14[REMOVED 
HYPERLINK FIELD]. The OLETF strain also shows hy-
perleptinemia, but there is no mutation in the leptin receptor 
gene15, and obesity is milder than in Zucker obese rats.
Hyperlipidemia is suggested to be an important factor 
for intestinal polyp formation in Apc-deficient mice from 
studies on suppression of hyperlipidemia by peroxisome 
proliferator-activated  receptor-α  and  receptor-γ  agonists 
and by Pai-1 blockers16,17. In our recent study, 20% caloric 
restriction reduced serum triglyceride and inhibited both 
AOM-induced colonic and Zymbal gland neoplasms in 
OLETF rats (data not shown). Hence, the hyperlipidemic 
state in OLETF rats may play a significant role in high sus-
ceptibility to intestinal carcinogenesis. Insulin and IGF-1, 
growth factors in vitro, increase in obesity. It is reported 
that insulin promoted AOM-induced colon carcinogenesis 
in F344 rats18. In the present experiments, the insulin levels 
in OLETF rats were diverse, and the hepatic IGF-1 mRNA 
level in OLETF rats was not different from that in LETO 
rats, suggesting that the role of hyperinsulinemia in carcino-
genesis is not distinct. However, the role of insulin and the 
molecular mechanisms of adipose tissue dysfunction should 
be further investigated4,5.
The data for the insulin levels in the OGTT in experi-
ment 1 and those without glucose load in experiment 2 were 
various. Although the measurement conditions were differ-
ent, AOM treatment might reduce insulin levels.
The Zymbal gland, a sebaceous gland of the external 
ear canal, is a target organ of AOM in rats19,20. In the present 
study, Zymbal gland tumor developed at a high rate, 67% 
in AOM-treated OLETF rats. However, in our recent study 
performed using the same protocol as the present study in 
nonobese Long-Evans Agouti rats21, a new model of type 2 
DM, the incidences of Zymbal gland, small intestine and 
colon tumors were 0%, 4% and 83%, respectively (unpub-
lished data). There is no description of Zymbal gland tumor 
in AOM-treated Zucker obese rats14. Therefore, the OLETF 
rat should be a strain susceptible to AOM-induced Zymbal 
gland carcinogenesis. It is known that both Zymbal glands and 
intestines in rats are target organs of heterocyclic amines in 
cooked foods such as 2-amino-3-methylimidazo[4,5-f]quino-
line,  2-amino-6-methyldipyrido[1,2-a:3′,2’-d]imidazole  and 
2-aminodipyrido[1,2-a:3′,2’-d]imidazole22. In humans, the 
familial disease of sebaceous carcinoma plus visceral can-
cer including colorectal carcinoma is known as Muir-Torre 
syndrome23, a variant of hereditary nonpolyposis colorectal 
cancer. The mechanism of susceptibility to Zymbal gland 
carcinogenesis in OLETF rats should be elucidated.
In conclusion, the hyperphagic OLETF strain is a use-
ful model for investigation of mechanisms of carcinogenesis 
and cancer prevention in diabetic conditions and obesity, 
and hyperlipidemia may play an important role in high sus-
ceptibility to Zymbal gland and intestinal carcinogenesis in 
OLETF rats.
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